Inverse relationship between cancer and Alzheimer’s disease: a systemic review meta-analysis

Neurological Sciences

Volumn 36, Issue 11, 2015, Pages 1987-1994

  Zhang, Qinghua ^a   Guo, Shougang ^a   Zhang, Xiao ^a   Tang, Shi ^a   Shao, Wen ^a   Han, Xiaojuan ^a   Wang, Lu ^a   Du, Yifeng ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Cancer; Meta analysis

Indexed keywords

APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; CANCER PATIENT; CANCER RISK; EDUCATIONAL STATUS; FOLLOW UP; GENETIC HETEROGENEITY; HUMAN; NEOPLASM; PUBLISHING; REVIEW; RISK REDUCTION; SAMPLE SIZE; SYSTEMATIC REVIEW; COMPLICATION; META ANALYSIS; NEOPLASMS;

ALZHEIMER DISEASE; HUMANS; NEOPLASMS;

EID: 84945476266     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2282-2     Document Type: Review

References (35)

1. Loy CT, Schofield PR, Turner AM, Kwok JBJ (2014) Genetics of dementia. Lancet 383(9919):828–840. doi:10.1016/s0140-6736(13)60630-3
2. Thies W, Bleiler L (2013) 2013 Alzheimer’s disease facts and figures. Alzheimer Dement 9(2):208–245. doi:10.1016/j.jalz.2013.02.003
3. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204–1222. doi:10.1016/j.cell.2012.02.040
4. Catala-Lopez F, Suarez-Pinilla M, Suarez-Pinilla P, Valderas JM, Gomez-Beneyto M, Martinez S, Balanza-Martinez V, Climent J, Valencia A, McGrath J, Crespo-Facorro B, Sanchez-Moreno J, Vieta E, Tabares-Seisdedos R (2014) Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom 83(2):89–105. doi:10.1159/000356498
5. Bajaj A, Driver JA, Schernhammer ES (2010) Parkinson’s disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 21(5):697–707. doi:10.1007/s10552-009-9497-6
6. Ibanez K, Boullosa C, Tabares-Seisdedos R, Baudot A, Valencia A (2014) Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet 10(2):e1004173. doi:10.1371/journal.pgen.1004173
7. Lai SW, Chen HJ, Lin CL, Liao KF (2014) No correlation between Alzheimer’s disease and risk of hepatocellular carcinoma in older people: an observation in Taiwan. Geriatr Gerontol Int 14(1):231–232. doi:10.1111/ggi.12141
8. White RS, Lipton RB, Hall CB, Steinerman JR (2013) Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk. Neurology 80(21):1966–1972. doi:10.1212/WNL.0b013e3182941990
9. Ou SM, Lee YJ, Hu YW, Liu CJ, Chen TJ, Fuh JL, Wang SJ (2013) Does Alzheimer’s disease protect against cancers? A nationwide population-based study. Neuroepidemiology 40(1):42–49. doi:10.1159/000341411
10. Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C, Palmer K, Russo A (2013) Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology 81(4):322–328. doi:10.1212/WNL.0b013e31829c5ec1
11. Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, Kiel DP, Lu KP, Seshadri S, Wolf PA (2012) Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study. BMJ 344:e1442
12. Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, Williams MM, Kopan R, Behrens MI, Morris JC (2010) Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74(2):106–112. doi:10.1212/WNL.0b013e3181c91873
13. Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC (2005) Alzheimer disease and cancer. Neurology 64(5):895–898. doi:10.1212/01.wnl.0000152889.94785.51
14. Yamada M, Sasaki H, Mimori Y, Kasagi F, Sudoh S, Ikeda J, Hosoda Y, Nakamura S, Kodama K (1999) Prevalence and risks of dementia in the Japanese population: RERF’s adult health study Hiroshima subjects. Radiation Effects Research Foundation. J Am Geriatr Soc 47(2):189–195
15. Ganguli M (2012) A reduced risk of Alzheimer’s disease in those who survive cancer. BMJ 344:e1662
16. DeSouky AL (1992) The relationship between cancer and Alzheimer’s disease. J Am Geriatr Soc 40(10):1075
17. Driver JA, Yung R, Gaziano JM, Kurth T (2010) Chronic disease in men with newly diagnosed cancer: a nested case–control study. Am J Epidemiol 172(3):299–308. doi:10.1093/aje/kwq127
18. Attner B, Lithman T, Noreen D, Olsson H (2010) Low cancer rates among patients with dementia in a population-based register study in Sweden. Dement Geriatr Cogn Disord 30(1):39–42. doi:10.1159/000315509
19. Hototian SR, Lopes MA, Azevedo D, Tatsch M, Bazzarella MC, Bustamante SE, Litvoc J, Bottino CM (2008) Prevalence of cognitive and functional impairment in a community sample from Sao Paulo, Brazil. Dement Geriatr Cogn Disord 25(2):135–143. doi:10.1159/000112554
20. Realmuto S, Cinturino A, Arnao V, Mazzola MA, Cupidi C, Aridon P, Ragonese P, Savettieri G, D’Amelio M (2012) Tumor diagnosis preceding Alzheimer’s disease onset: is there a link between cancer and Alzheimer’s disease? J Alzheimers Dis 31(1):177–182. doi:10.3233/jad-2012-120184
21. Burke WJ, McLaughlin JR, Chung HD, Gillespie KN, Grossberg GT, Luque FA, Zimmerman J (1994) Occurrence of cancer in Alzheimer and elderly control patients: an epidemiologic necropsy study. Alzheimer Dis Assoc Disord 8(1):22–28
22. Desai MM, Bruce ML, Desai RA, Druss BG (2001) Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol 153(3):299–306
23. Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T (2013) A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 39(3):297–304. doi:10.1016/j.ctrv.2012.11.001
24. Surma-aho O, Niemela M, Vilkki J, Kouri M, Brander A, Salonen O, Paetau A, Kallio M, Pyykkonen J, Jaaskelainen J (2001) Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56(10):1285–1290
25. Caamano-Isorna F, Corral M, Montes-Martinez A, Takkouche B (2006) Education and dementia: a meta-analytic study. Neuroepidemiology 26(4):226–232. doi:10.1159/000093378
26. Roe CM, Xiong C, Miller JP, Morris JC (2007) Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis. Neurology 68(3):223–228. doi:10.1212/01.wnl.0000251303.50459.8a
27. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 120(4):545–555. doi:10.1016/j.cell.2005.02.008
28. Driver JA, Lu KP (2010) Pin1: a new genetic link between Alzheimer’s disease, cancer and aging. Curr Aging Sci 3(3):158–165
29. Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, Wulf G, Lim J, Li SH, Li X, Xia W, Nicholson LK, Lu KP (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440(7083):528–534. doi:10.1038/nature04543
30. Liou YC, Sun A, Ryo A, Zhou XZ, Yu ZX, Huang HK, Uchida T, Bronson R, Bing G, Li X, Hunter T, Lu KP (2003) Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424(6948):556–561. doi:10.1038/nature01832
31. van Heemst D, Mooijaart SP, Beekman M, Schreuder J, de Craen AJ, Brandt BW, Slagboom PE, Westendorp RG (2005) Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 40(1–2):11–15
32. Behrens MI, Lendon C, Roe CM (2009) A common biological mechanism in cancer and Alzheimer’s disease? Curr Alzheimer Res 6(3):196–204
33. Holohan KN, Lahiri DK, Schneider BP, Foroud T, Saykin AJ (2012) Functional microRNAs in Alzheimer’s disease and cancer: differential regulation of common mechanisms and pathways. Front Genet 3:323. doi:10.3389/fgene.2012.00323
34. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Method 1(2):97–111. doi:10.1002/jrsm.12
35. Rothstein HR, Sutton AJ, Borenstein M (2006) Publication bias in meta-analysis: prevention, assessment and adjustments. John Wiley & Sons